To healthy male subjects of 30, following treatments are administered dosing in each 3 period(Lobeglitazone or Empagliflozin or Lobe.+Empa.) and wash-out period is a minimum of 7 days.~Test Drug 1: Lobeglitazone 0.5mg 1T~Test Drug 2: Empagliflozin 25mg 1T~Pharmacokinetic blood samples are collected up to 24hrs.~Safety, pharmacokinetic and the drug-drugs interaction are assessed.
This study is a randomized, open-label, multiple dosing, crossover study to evaluate the drug-drugs interaction between Lobeglitazone and Empagliflozin in healthy male volunteers